Synergistic activity of SCD1 blockade in combination with tyrosine kinase inhibitors lenvatinib and cabozantinib in hepatocellular carcinoma (HCC)Justyna J. Gleba,Aylin Alasonyalilar-Demirer, Matthew L. Pawlush, Ahmet Bilgili, Peyton G. Hickman,Kabir Mody,Lewis R. Roberts,Steven R. Alberts,Mark J. Truty,Tushar C. Patel,Han W. Tun,John A. CoplandCANCER RESEARCH（2023）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
